Arthroplasty

Industry Stakeholders in Hip Replacement Implants Market Aim at Implant Modifications to Improve Outcomes in Total Hip Arthroplasty (THA): TMR

Retrieved on: 
Thursday, March 18, 2021
Surgery, Medical specialties, Medicine, Prosthetics, Hip replacement, Arthroplasty, Oxinium, Knee replacement

Modifications in hip replacement implants have thus gained groundswell of attention for implant manufacturers and healthcare teams.

Key Points: 
  • Modifications in hip replacement implants have thus gained groundswell of attention for implant manufacturers and healthcare teams.
  • In recent decades, such product advancements have gathered momentum on back of growing demand for total hip arthroplasty (THA).
  • Other factors such as advancements in surgical techniques and the focus on reducing the revision rates have all contributed to the evolution of the hip replacement implants market.
  • Growing number of hip reconstruction procedures is expected to propel the hip replacement implants market.

Catalyst OrthoScience Receives FDA 510(k) Clearance of Its Reverse Shoulder System

Retrieved on: 
Wednesday, March 17, 2021
FDA, Health, Medical devices, Medical specialties, Surgery, Clinical medicine, Arthritis, Orthopedic surgery, Arthroplasty, Reverse shoulder replacement, Catalysis, Prosthetics

Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system.

Key Points: 
  • Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has received clearance from the U.S. Food & Drug Administration (FDA) to market its reverse shoulder system.
  • The addition of the reverse shoulder system allows Catalyst to offer a broader shoulder portfolio and multiple arthroplasty options to shoulder surgeons across the U.S.
  • With the addition of our reverse shoulder system, Catalyst is now addressing the two fastest growing segments of the shoulder arthroplasty market stemless anatomic and reverse TSA, said Brian K. Hutchison , chairman and CEO of Catalyst.
  • Catalysts reverse shoulder system is a single-tray arthroplasty system that was engineered to combine the most beneficial and evidence-based attributes of reverse shoulder arthroplasty design.

OrthoGrid Systems, Inc. Announces Launch of New OrthoGrid Hip Software Application for Direct Anterior Approach Total Hip Arthroplasty

Retrieved on: 
Tuesday, February 23, 2021
Medical specialties, Prosthetics, Medicine, Clinical medicine, Pelvis, Hip replacement, THA, Arthroplasty, Implant

The new OrthoGrid Hip is the latest version of OrthoGrid System's patented, distortion-correcting, implant-agnostic, intraoperative-alignment technology for direct anterior hip total hip arthroplasty (DAA THA) offered on the company's AI-enabled digital platform.

Key Points: 
  • The new OrthoGrid Hip is the latest version of OrthoGrid System's patented, distortion-correcting, implant-agnostic, intraoperative-alignment technology for direct anterior hip total hip arthroplasty (DAA THA) offered on the company's AI-enabled digital platform.
  • In addition, the new OrthoGrid Hip enables surgeons to get precise leg length and hip offset measurements to achieve their desired biomechanical alignment.
  • "We are thrilled to bring this latest version of our OrthoGrid Hip software to market," says Richard Boddington, co-founder and co-CEO of OrthoGrid.
  • OrthoGrid Hip is an image-processing software indicated to assist in the positioning of Total Hip Replacement components.

FX Solutions, SAS. [FX Shoulder, Inc.] Receives FDA 510k Clearance for Easytech® Stemless Anatomic Shoulder Replacement

Retrieved on: 
Thursday, February 18, 2021
Musculoskeletal system, Medical Subject Headings, Surgery, Arthritis, Prosthetics, Shoulder replacement, Rotator cuff, Shoulder joint, Arthroplasty, Osteoarthritis, Shoulder

The design of the Easytech Anchor base allows for the device to fit peripherally just inside the cortical bone where bone quality is optimal for fixation.

Key Points: 
  • The design of the Easytech Anchor base allows for the device to fit peripherally just inside the cortical bone where bone quality is optimal for fixation.
  • The Easytech Anchor base is a stemless prosthesis that is intended to treat a severely painful and/or disabled shoulder joint with a functional rotator cuff and resulting from osteoarthritis.
  • FX Shoulder USA, Inc. is based in Dallas, TX and is the direct provider of FX Solutions shoulder replacement devices in the U.S. FX Shoulder USA, Inc., founded in January 2018, focuses exclusively on shoulder arthroplasty.For additional information, please visit www.fxshoulder.com .
  • *FX does not make any claims about the use of TiN coating for nickel allergy patients.

Newly Published Study With the Stemless Catalyst CSR™ Total Shoulder System Demonstrates Good Results in Adult Arthroplasty Patients of All Ages at 2-3 Year Follow-Up

Retrieved on: 
Wednesday, February 17, 2021
Biotechnology, Surgery, Medical devices, Other Health, Health, Medical specialties, Arthritis, Clinical medicine, Arthroplasty, Medicine, Prosthetics

The retrospective case series examines the initial cohort of patients that received an anatomic total shoulder arthroplasty (TSA) using the Catalyst CSR system from August 2016 to August 2017.

Key Points: 
  • The retrospective case series examines the initial cohort of patients that received an anatomic total shoulder arthroplasty (TSA) using the Catalyst CSR system from August 2016 to August 2017.
  • Sixty-three shoulders in 57 patients with a mean age of 73 years (range of 60-85 years old) were included in the study.
  • This study provides evidence that the stemless, ellipsoid Catalyst CSR system may be used safely in adult arthroplasty patients of all ages with good clinical outcomes.
  • The Catalyst CSR Total Shoulder System is unique, offering precision and accuracy in shoulder restoration while preserving the patients bone and soft tissue.

Surgical Planning Associates Receives FDA Clearance for New HipInsight™ Augmented Reality System for Joint Arthroplasty

Retrieved on: 
Wednesday, February 10, 2021
Surgery, Medical specialties, Clinical medicine, Prosthetics, Computer-assisted surgery, Joint replacement, Applications of computer vision, User interface techniques, Arthroplasty, Surgical planning, Hip replacement, Augmented reality

BOSTON, Feb. 10, 2021 /PRNewswire/ -- Surgical Planning Associates (SPA) today announced a major step forward in how surgery can be performed with the introduction of its HipInsight augmented reality (AR) intra-operative guidance system for joint arthroplasty.

Key Points: 
  • BOSTON, Feb. 10, 2021 /PRNewswire/ -- Surgical Planning Associates (SPA) today announced a major step forward in how surgery can be performed with the introduction of its HipInsight augmented reality (AR) intra-operative guidance system for joint arthroplasty.
  • Dr. Stephen B. Murphy, founder of SPA, performed the first total hip arthroplasty using the HipInsight system last Thursday the first such surgery ever performed using an augmented reality system.
  • Surgical Planning Associates , Inc. (SPA) is an ISO 13485:2016 certified medical technology company that specializes in the development of innovative, cost-effective preoperative planning and navigation solutions for use in joint arthroplasty.
  • A pioneer in the fields of surgical planning and computer-assisted joint reconstruction, SPA is privately held and based in Boston.

Concentric Analgesics Announces Additional Positive Results from Phase 2 Clinical Trial of Vocacapsaicin (CA-008) in Total Knee Arthroplasty Surgery

Retrieved on: 
Tuesday, January 26, 2021
Research, Surgery, Hospitals, Clinical trials, Biotechnology, Health, Pharmaceutical, General Health, Science, Medical specialties, Clinical medicine, Medicine, Skeletal disorders, Prosthetics, Acute pain, Knee replacement, Osteoarthritis, Arthroplasty, Pain, Arthritis

The study, conducted in 187 patients undergoing total knee arthroplasty (TKA), evaluated the effects on reported pain, opioid consumption, safety and pharmacokinetics of vocacapsaicin over 28 days.

Key Points: 
  • The study, conducted in 187 patients undergoing total knee arthroplasty (TKA), evaluated the effects on reported pain, opioid consumption, safety and pharmacokinetics of vocacapsaicin over 28 days.
  • The reductions in pain at rest and with ambulation for the 36 mg dose of vocacapsaicin continued throughout the two weeks after surgery.
  • Based on the available Phase 2 results and discussions with the FDA, the company will evaluate additional surgical models while finalizing plans for Phase 3.
  • Concentric has two additional active programs for multiple indications with significant unmet medical need: osteoarthritis pain and chronic refractory pain.

Pioneer in Robotic Joint Replacement Surgery Joins World #1 in Orthopedics at HSS Florida

Retrieved on: 
Tuesday, January 19, 2021
Medical specialties, Prosthetics, Clinical medicine, Medicine, Joint replacement, Knee replacement, Arthroplasty

Dr. Roche joins HSS Florida from Holy Cross Hospital, where he served as Director of the Robotic Joint Fellowship and has been in practice since 1996.

Key Points: 
  • Dr. Roche joins HSS Florida from Holy Cross Hospital, where he served as Director of the Robotic Joint Fellowship and has been in practice since 1996.
  • Dr. Roche is joining Dr. John L. Wang , and will lead the hip and knee joint replacement program as Director of Hip and Knee Arthroplasty at HSS Florida.
  • The HSS Florida joint replacement program is focused on expanding HSS's expert-level care to Florida's active growing population.
  • The total joint replacement program at HSS Florida comes at a pivotal time, as many Americans remain concerned about COVID-19 exposure.

DePuy Synthes Receives 510(k) FDA Clearance for VELYS™ Robotic-Assisted Solution Designed for Use with the ATTUNE® Total Knee System

Retrieved on: 
Tuesday, January 19, 2021
Surgery, Medical specialties, Johnson & Johnson, Medicine, DePuy, Synthes, Knee replacement, Arthroplasty, Knee, Orthopedic surgery

Coupled with the ATTUNE Total Knee, the VELYS Robotic-Assisted Solution is highly differentiated and can help improve clinical outcomes and increase patient satisfaction, providing a more attractive clinical solution to current options on the market," said Aldo Denti, Company Group Chairman, DePuy Synthes Franchise****.

Key Points: 
  • Coupled with the ATTUNE Total Knee, the VELYS Robotic-Assisted Solution is highly differentiated and can help improve clinical outcomes and increase patient satisfaction, providing a more attractive clinical solution to current options on the market," said Aldo Denti, Company Group Chairman, DePuy Synthes Franchise****.
  • DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopaedics portfolios in the world.
  • **DePuy Synthes represents the products and services of DePuy Synthes, Inc. and its affiliates.
  • Modifications of femoral component design in multi-radius total knee arthroplasty lead to higher lateral posterior femoro-tibial translation.

2020 Insights on Extremity Replacement Implants - Arthroplasty Procedure Volumes - ResearchAndMarkets.com

Retrieved on: 
Tuesday, January 12, 2021
Health, Other Health, Medical specialties, Medicine, Prosthetics, Clinical medicine, Joint replacement, Arthroplasty, Elbow

The "Extremity Replacement Implants" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Extremity Replacement Implants" report has been added to ResearchAndMarkets.com's offering.
  • This medical market and technology report provides a comprehensive discussion of the global market for extremities replacement implants.
  • Market forecasts and competitive analyses are provided for the shoulder, elbow, ankle, and small joint arthroplasty devices markets.
  • This report provides the following useful information:
    in-depth market and competitive analyses.